Notice of National Heart, Lung, and Blood Institute (NHLBI) Participation in RFA-HG-15-002 "Centers for Mendelian Genomics (UM1)"

Notice Number: NOT-HL-15-251

Key Dates
Release Date: January 30, 2015

Related Announcements
RFA-HG-15-002

Issued by
National Human Genome Research Institute (NHGRI)
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating, effective immediately, in RFA-HG-15-002 "Centers for Mendelian Genomics (UM1)". 

The following sections of RFA-HG-15-002 have been updated to reflect NHLBI's participation in this funding opportunity announcement. 

Part 1.  Overview Information

Components of Participating Organizations
National Human Genome Research Institute (NHGRI)
National Heart, Lung, and Blood Institute (NHLBI)

Catalog of Federal Domestic Assistance (CFDA) Numbers
93.172, 93.837, 93.838, 93.839, 93.233

Part 2.  Section II.  Award Information

Funds Available and Anticipated Number of Awards
NHLBI intends to provide up to $2M total costs per year for four years to co-fund awards relevant to the NHLBI mission.

Part 2.  Section VII. Agency Contacts

Scientific/Research Contact(s)
Weiniu Gan, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone:  301-435-0202
Email:  ganw2@mail.nih.gov

Financial/Grants Management Contact(s)
Gayle Jones
National Heart, Lung, and Blood Institute (NHLBI)
Telephone:  301-435-0140
Email:  jonesgt@mail.nih.gov

Inquiries

Please direct all inquiries to:

Weiniu Gan, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone:  301-435-0202
Email:  ganw2@mail.nih.gov